Private Market View

Epicrispr Biotechnologies

San Francisco, CA · Founded 2018 · Privately Held (backing)

Last price · $/share
Implied valuation
$185.0M
Total raised
$123.0M
Last round
What is Epicrispr Biotechnologies worth?
$185.0Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 4 names
  • ·Watchlist + deal alerts for Epicrispr Biotechnologies
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for Epicrispr Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Epicrispr Biotechnologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Epicrispr Biotechnologies, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Epicrispr Biotechnologies worth?
Epicrispr Biotechnologies's last known valuation is $185.0M.
How much has Epicrispr Biotechnologies raised?
Epicrispr Biotechnologies has raised $123.0M in total funding across its recorded rounds.
Epicrispr Biotechnologies Valuation 2026 — $185.0M | Private Market View